The Endowment Board has delegated authority from Council to manage the College’s investments under College Ordinances. The Chair of the Endowment Board provides regular updates to Council. Read the Endowment Board's Terms of Reference in the College Regulations for more information on the Endowment Board's remit.
The Board has majority representation from non-executive members with market experience and expertise consistent with the Endowment’s investments.
The membership of the Board is as follows:
- Vindi Banga (Partner, Clayton Dubilier & Rice) (interim Chair)
- Annabel Rudebeck (Head of Non-US Credit, Western Asset Management)
- Lisha Patel (Managing Director, Wellcome Trust)
- Anastasia Shiach (Executive Director, Goldman Sachs)
- James Seppala (Head of Real Estate Europe, Blackstone)
- Subhanu Saxena (Managing Partner, New Rhein Healthcare LLC)
- Hugh Brady (President, Imperial College London) (ex officio)
- Robert Kerse (Chief Operating Officer, Imperial College London) (ex officio)
The Board provides oversight and approves all strategic decisions, including asset allocation. Members of the Endowment Board are assigned responsibility for a portfolio in line with their expertise and are supported by university staff.
The Unitised Scheme is segmented into three different investment types:
- Marketable assets – the Endowment Board member lead is Annabel Rudebeck, supported by Tony Lawrence (Chief Financial Officer)
- Endowment Property – the Endowment Board member lead is James Seppala, supported by John Anderson (Chief Investment Officer)
- Private equity funds – The Endowment Board member lead is Lisha Patel, supported by John Anderson (Chief Investment Officer)
The Endowment Board is overseen by the College Council and is supported by the Endowment Secretariat.